InvestorsHub Logo
Followers 19
Posts 1039
Boards Moderated 0
Alias Born 04/18/2018

Re: Rogue3 post# 35898

Wednesday, 04/06/2022 4:59:55 PM

Wednesday, April 06, 2022 4:59:55 PM

Post# of 35961
Agreed: From 8-K 10/12/21....The company expects to provide a further clinical update in the first half of 2022. The Company is also in the process of launching and rebranding its new corporate website at www.rebus-corp.com.
The company anticipates that subsequent to the reverse split it will be able to apply to list its Common Stock on the OTCQB tier of the OTC Markets Group, and eventually apply for a listing on a national exchange, in order to provide stockholders with more liquidity and allow the company more flexibility in accessing the capital markets.


I guess Silvestre is behind schedule on some of his ambitions noted in the merger documents. However, like most things these days he can blame covid as the root cause of the delays.